RSH 0.00% 2.9¢ respiri limited

Ann: Remote Patient Monitoring presentation, page-3

  1. 112 Posts.
    lightbulb Created with Sketch. 46
    RSH is part of a very full agenda, but hopefully the audience at BIoshares recognizes the strong operational position the company is in and the enormous commercial potential given the favourable RPM reimbursed market in the US across the chronic diseases RSH now supports post merger with Access.
    Getting new investors interested at these entry levels must be attractive with these brokers looking like heroes over the next 12 - 24 months.
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.